Paper Details 
Original Abstract of the Article :
Patient harm from inadvertent administration of amphotericin B (Fungizone&#8482;) instead of liposomal amphotericin (AmBisome<sup>&#174;</sup>) has been described in the literature and has been the subject of patient safety alerts in the UK. Safe use of intravenous amphotericin depends on the knowle...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s40261-020-00924-4

データ提供:米国国立医学図書館(NLM)

Amphotericin: A Powerful Antifungal Agent with Potential for Error

Amphotericin B, a potent antifungal agent, is commonly used to treat serious fungal infections. This review focuses on the [potential for error] associated with the administration of amphotericin B, particularly the risk of [inadvertent administration of amphotericin B instead of liposomal amphotericin (AmBisome)]. The authors explore the factors contributing to this type of medication error and propose recommendations for reducing the risk of harm to patients.

The Importance of Clear Distinction: Avoiding Amphotericin Errors

This review highlights the importance of [clarity and distinction] in the labeling and packaging of medications, particularly those with similar names or appearances, like amphotericin B and AmBisome. The authors point to the potential for [medication errors] due to the similarity in these products and emphasize the need for [robust safety protocols] to minimize the risk of harm to patients.

Safeguarding Patient Safety: Reducing the Risk of Medication Errors

This review underscores the crucial role of [patient safety] in healthcare delivery. The authors emphasize the importance of [clear communication, robust protocols, and careful medication administration] to minimize the risk of medication errors. By implementing these safety measures, healthcare professionals can ensure that patients receive the correct medications and dosages, minimizing the risk of adverse events and promoting optimal outcomes.

Dr.Camel's Conclusion

This review emphasizes the need for vigilance and robust safety protocols to ensure the safe and effective administration of amphotericin B. Just as a desert traveler must carefully navigate the landscape to avoid hidden dangers, healthcare professionals must be mindful of the potential for medication errors, especially with medications that share similar names or appearances. By prioritizing patient safety and implementing comprehensive strategies to reduce the risk of errors, we can protect the well-being of individuals receiving amphotericin B and ensure their successful recovery.

Date :
  1. Date Completed 2020-10-14
  2. Date Revised 2020-10-14
Further Info :

Pubmed ID

32514939

DOI: Digital Object Identifier

10.1007/s40261-020-00924-4

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.